Andrew was Head of Neurodegenerative Franchise at Taysha Gene Therapies, and Vice President of Clinical Development at Reata Pharmaceuticals. Andrew Cunningham joined CalciMedica in 2023.
Andrew Cunningham is currently
Create your alert
to follow the career of Andrew Cunningham.
Do you need to know more about Andrew Cunningham? More results.
Report an error
Update the org chart details of Andrew Cunningham.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.